DFM Funding Monitor

Innovative Photoactivated Ruthenium Chemotherapy to treat eye cancerbroad

PACT4EYE · Horizon Europe grant · 2023-11-01–2026-10-31

EC contribution

€2,499,999

Total cost

€2,499,999

Beneficiaries

4

About the data

Source: CORDIS (official EU open data), Horizon Europe. Framework HORIZON · call HORIZON-EIC-2023-TRANSITION-01 · scheme HORIZON-EIC · topic HORIZON-EIC-2023-TRANSITIONOPEN-01. CORDIS record →

Objective

Uveal melanoma (UM) is a rare tumor of the eye

Beneficiaries (4)

Organisation	Country	Role	EC contribution	SME
UNIVERSITEIT LEIDEN	NL	coordinator	€1,021,624
RECORNEA SRL	IT	participant	€534,625	Yes
ACADEMISCH ZIEKENHUIS LEIDEN	NL	participant	€471,875
INSTITUT CURIE	FR	participant	€471,875

Get the EU Defence Funding Calendar — free

The full calendar of open EU defence and dual-use funding calls, sorted by deadline, updated nightly. Delivered with DFM Analysis, our weekly briefing on who is funding what in European defence.

Get the calendar

Yes — subscribe me to DFM Analysis, the free weekly briefing on European defence funding, and send me the monthly funding calendar. Unsubscribe anytime.

Website

We store your email to send the calendar and the weekly DFM Analysis briefing. Nothing else. Unsubscribe anytime.

Or browse all open defence & dual-use calls on the funding calendar →

Defence Finance Monitor is an analytical and informational product. Grant data is official CORDIS; the paid Annual Professional subscription is handled on DFM Analysis.